Correlation Between Aclaris Therapeutics and Cabaletta Bio
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and Cabaletta Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and Cabaletta Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and Cabaletta Bio, you can compare the effects of market volatilities on Aclaris Therapeutics and Cabaletta Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of Cabaletta Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and Cabaletta Bio.
Diversification Opportunities for Aclaris Therapeutics and Cabaletta Bio
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aclaris and Cabaletta is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and Cabaletta Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabaletta Bio and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with Cabaletta Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabaletta Bio has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and Cabaletta Bio go up and down completely randomly.
Pair Corralation between Aclaris Therapeutics and Cabaletta Bio
Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 11.46 times less return on investment than Cabaletta Bio. But when comparing it to its historical volatility, Aclaris Therapeutics is 1.81 times less risky than Cabaletta Bio. It trades about 0.01 of its potential returns per unit of risk. Cabaletta Bio is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 236.00 in Cabaletta Bio on August 20, 2025 and sell it today you would earn a total of 3.00 from holding Cabaletta Bio or generate 1.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aclaris Therapeutics vs. Cabaletta Bio
Performance |
| Timeline |
| Aclaris Therapeutics |
| Cabaletta Bio |
Aclaris Therapeutics and Cabaletta Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aclaris Therapeutics and Cabaletta Bio
The main advantage of trading using opposite Aclaris Therapeutics and Cabaletta Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, Cabaletta Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabaletta Bio will offset losses from the drop in Cabaletta Bio's long position.| Aclaris Therapeutics vs. Cabaletta Bio | Aclaris Therapeutics vs. Exagen Inc | Aclaris Therapeutics vs. Editas Medicine | Aclaris Therapeutics vs. NeoGenomics |
| Cabaletta Bio vs. Editas Medicine | Cabaletta Bio vs. Allogene Therapeutics | Cabaletta Bio vs. Capricor Therapeutics | Cabaletta Bio vs. Kyverna Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |